 Trans-Activators
"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.
| Descriptor ID |
D015534
|
| MeSH Number(s) |
D12.776.260.755 D12.776.930.900 D12.776.964.925.984
|
| Concept/Terms |
Trans-Activators- Trans-Activators
- Trans Activators
- Transactivators
- Trans-Activator
- Trans Activator
- Transactivator
- Trans-Acting Factor
- Factor, Trans-Acting
- Trans Acting Factor
- Trans-Acting Factors
- Factors, Trans-Acting
- Trans Acting Factors
Nuclear Trans-Acting Factor- Nuclear Trans-Acting Factor
- Factor, Nuclear Trans-Acting
- Nuclear Trans Acting Factor
- Trans-Acting Factor, Nuclear
|
Below are MeSH descriptors whose meaning is more general than "Trans-Activators".
Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".
This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 3 | 6 | | 1997 | 11 | 1 | 12 | | 1998 | 5 | 3 | 8 | | 1999 | 10 | 1 | 11 | | 2000 | 5 | 3 | 8 | | 2001 | 5 | 2 | 7 | | 2002 | 12 | 10 | 22 | | 2003 | 17 | 5 | 22 | | 2004 | 24 | 16 | 40 | | 2005 | 14 | 10 | 24 | | 2006 | 10 | 7 | 17 | | 2007 | 6 | 4 | 10 | | 2008 | 6 | 3 | 9 | | 2009 | 7 | 4 | 11 | | 2010 | 6 | 10 | 16 | | 2011 | 2 | 4 | 6 | | 2012 | 6 | 5 | 11 | | 2013 | 5 | 5 | 10 | | 2014 | 3 | 5 | 8 | | 2015 | 4 | 3 | 7 | | 2016 | 1 | 4 | 5 | | 2017 | 6 | 7 | 13 | | 2018 | 3 | 3 | 6 | | 2019 | 5 | 5 | 10 | | 2020 | 4 | 4 | 8 | | 2021 | 6 | 3 | 9 | | 2022 | 0 | 4 | 4 | | 2023 | 1 | 3 | 4 | | 2024 | 1 | 0 | 1 | | 2025 | 1 | 1 | 2 | | 2026 | 1 | 4 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Trans-Activators" by people in Profiles.
-
Sottnik JL, Shackleford MT, Nesiba CS, Richer AL, Fleischmann Z, Swartz JM, Rowland CE, Musick M, Fu R, Myler LR, Opresko PL, Mehrotra S, Sokol ES, Hesselberth JR, Diamond JR, Sikora MJ. Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition. Cancer Res. 2026 Apr 02; 86(7):1605-1621.
-
Federico A, Schmitt-Hoffner F, Fonseca A, Geisemeyer N, Bruckner K, Mauermann M, Sill M, Stichel D, Sturm D, Schüller U, Tauziede-Espariat A, Varlet P, Capper D, Abdullaev Z, Schrimpf D, Selt F, Williamson L, Donson AM, Antonelli M, Miele E, Snuderl M, Brandner S, Lastowska M, van der Lugt J, Bunt J, Kramm C, Kolenova A, Raghunathan A, Wilson Y, Weintraub L, Hansford JR, Spiegl-Kreinecker S, Aistleitner B, Baroni L, Zapotocky M, Ramaswamy V, Korshunov A, Jones B, Kjaersgaard M, Kranendonk ME, Haberler C, Packer RJ, Jäger N, von Deimling A, Sahm F, Koster J, Aldape K, Pfister SM, von Hoff K, Gojo J, Kool M. Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies. Neuro Oncol. 2026 Apr 01; 28(4):1005-1019.
-
Denson AM, Rodriguez KE, Letourneau-Freiberg LR, Kandasamy B, Naylor RN, Abdullatif HD, Benjamin RW, Cobry E, Freemark MS, Thomas IH, Greeley SAW. Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1164-e1173.
-
John MS, Chinnappan M, Sturges CI, Artami M, Bhattacharya M, Keogh RA, Kavanaugh JS, Jain S, Gedamu H, Komarovsky J, Velasquez M, Sharma T, McDonald JG, Horswill AR, Harris-Tryon TA. Skin androgens regulate Staphylococcus aureus pathogenicity via quorum sensing. Nat Microbiol. 2026 Mar; 11(3):704-717.
-
Nelson CB, Wells JK, Kesarwani E, Sobinoff AP, Fernando M, Gao J, MacKenzie KL, Poulos RC, Nawaz U, Wang X, Ford HL, Pickett HA. Potent synthetic lethality between PLK1 and EYA family inhibitors in tumors of the central and peripheral nervous systems. Genes Dev. 2026 02 02; 40(3-4):267-283.
-
Bagood MD, Marjanovic J, Jiang N, Chan H, Dokoshi T, Cavagnero KJ, Li F, Roso-Mares A, Almoughrabie S, Liu E, Pastar I, Tomic-Canic M, Horswill AR, Gallo RL. Staphylococcus aureus accessory gene regulator quorum-sensing system inhibits keratinocyte lipid enzymes and delays wound repair. J Clin Invest. 2025 Oct 15; 135(20).
-
Johnson M, Mehrotra S. Mucoepidermoid carcinoma lacking squamous component arising in rare location: utility of MAML2 genetic testing for diagnosis. BMJ Case Rep. 2025 Jan 21; 18(1).
-
Singh S, Arya G, Mishra R, Singla S, Pratap A, Upadhayay K, Sharma M, Chaba R. Molecular mechanisms underlying allosteric behavior of Escherichia coli DgoR, a GntR/FadR family transcriptional regulator. Nucleic Acids Res. 2025 Jan 07; 53(1).
-
Musaev D, Abdelmessih M, Vejnar CE, Yartseva V, Weiss LA, Strayer EC, Takacs CM, Giraldez AJ. UPF1 regulates mRNA stability by sensing poorly translated coding sequences. Cell Rep. 2024 04 23; 43(4):114074.
-
Wilkening RV, Langouët-Astrié C, Severn MM, Federle MJ, Horswill AR. Identifying genetic determinants of Streptococcus pyogenes-host interactions in a murine intact skin infection model. Cell Rep. 2023 11 28; 42(11):113332.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|